Kamada (KMDA) Share-based Compensation (2012 - 2026)
Kamada (KMDA) reported Share-based Compensation of $800000.0 for Q1 2026, up 357.14% on a YoY basis from $175000.0 in Q1 2025, and up 74.67% quarter-over-quarter from $458000.0 in Q4 2025.
Kamada (KMDA) Share-based Compensation (2012 - 2026) Analysis & Trends
Kamada has reported Share-based Compensation for 15 years, with the latest figure at $800000.0 in Q1 2026.
- For the quarter ending Q1 2026, Share-based Compensation rose 357.14% year-over-year to $800000.0; the trailing twelve-month figure through Mar 2026 stood at $1.5 million (up 83.52% YoY), and the FY2025 full-year result was $845000.0, down 2.54% from the prior year.
- Share-based Compensation for Q1 2026 stood at $800000.0, up from $458000.0 in the prior quarter.
- The five-year high for Share-based Compensation was $800000.0 in Q1 2026, with the low at $218.0 in Q4 2022.
- Historically, Share-based Compensation has averaged $234176.4 across 5 years, with a median of $214000.0 in 2023.
- The largest YoY upside for Share-based Compensation was 171000.92% in 2023 against a maximum downside of 99.78% in 2023.
- Kamada's Share-based Compensation stood at $218.0 in 2022, then surged by 171000.92% to $373000.0 in 2023, then tumbled by 55.23% to $167000.0 in 2024, then surged by 174.25% to $458000.0 in 2025, then soared by 74.67% to $800000.0 in 2026.
- The last three Share-based Compensation figures came in at $800000.0 (Q1 2026), $458000.0 (Q4 2025), and $117000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 43.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 25.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 33.90 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | -395,114.54 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 57.20 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 21.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 36.33 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 36.86 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 16.04 Mn |
| 10 | Kamada | 504.70 | -73.15 Mn | 19.12 Mn | 800,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 800,000.00 |
| Mar 31, 2026 | 800,000.00 |
| Dec 31, 2025 | 458,000.00 |
| Dec 31, 2025 | 458,000.00 |
| Sep 30, 2025 | 117,000.00 |
| Sep 30, 2025 | 117,000.00 |
| Jun 30, 2025 | 95,000.00 |
| Jun 30, 2025 | 95,000.00 |
| Mar 31, 2025 | 175,000.00 |
| Mar 31, 2025 | 175,000.00 |
| Dec 31, 2024 | 167,000.00 |
| Dec 31, 2024 | 167,000.00 |
| Sep 30, 2024 | 224,000.00 |
| Sep 30, 2024 | 224,000.00 |
| Jun 30, 2024 | 235,000.00 |
| Jun 30, 2024 | 235,000.00 |
| Mar 31, 2024 | 241,000.00 |
| Mar 31, 2024 | 241,000.00 |
| Dec 31, 2023 | 373,000.00 |
| Dec 31, 2023 | 373,000.00 |